Cargando…
Combination of Iodine-125 brachytherapy and chemotherapy for locally recurrent stage III non-small cell lung cancer after concurrent chemoradiotherapy
BACKGROUND: Locally recurrent non-small cell lung cancer (NSCLC) poses a great challenge to physicians. This study aimed to explore the efficacy and safety of the combination of brachytherapy and docetaxel and cisplatin for the treatment of locally recurrent stage III NSCLC. METHODS: Fifty two patie...
Autores principales: | Yu, Xiaojuan, Li, Jin, Zhong, Xiaoming, He, Jingdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596375/ https://www.ncbi.nlm.nih.gov/pubmed/26445227 http://dx.doi.org/10.1186/s12885-015-1657-3 |
Ejemplares similares
-
CT-guided iodine-125 brachytherapy as salvage therapy for local-regional recurrent breast cancer
por: Wang, Juan, et al.
Publicado: (2023) -
Concurrent Chemoradiotherapy without Brachytherapy in Locally Advanced Cervical Cancer
por: Kadkhodayan, Sima, et al.
Publicado: (2013) -
Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020) -
Efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in the treatment of advanced NSCLC in the elderly
por: Wu, Chunrong, et al.
Publicado: (2018) -
Salvage treatment of NSCLC recurrence after first‐line chemotherapy failure: Iodine‐125 seed brachytherapy or microwave ablation?
por: Liu, Bin, et al.
Publicado: (2020)